Rossix.blue.jpg
Home Products About Us Contact
img_8384.jpg

Chromogenic Kits

Learn more about our Chromogenic Kits.

Phospholipid Emulsions

Our highly stable phospholipid emulsions are suitable for use in analyses related to procoagulant and anticoagulant pathways.

References

Mission References

Steffen Rosén

Senior Consultant Scientific and Medical Affairs

steffen.rosen@rossix.com

Steffen Rosén has a background as PhD in biochemistry and started his career at Kabi Diagnostica 1978. He expanded the bioreagent purification and was responsible for the development of Coatest Factor VIII, the first chromogenic FVIII kit. He became head of coagulation research and later Director R&D and VP Scientific and Medical Affairs at Chromogenix.

Under his guidance, several chromogenic kits in coagulation and fibrinioysis were developed as well as the clotting based Coatest APC Resistance Kit. Steffen was also the technical expert in patent matters at Chromogenix.

Steffen Rosén has more than 30 ​years experience from his work at Kabi Diagnostica and later Chromogenix in development of methods and products in Hemostasis.

In 2000 Steffen founded the company Rossix.

News

2019-06-20 ISTH, Melbourne July 6-10, 2019.

Rossix will present three posters related to analysis of Factor IX at the ISTH in Melbourne:

PB0099 - Evaluation of Lupus Anticoagulant interference in a chromogenic Factor IX kit for determination of

Factor IX activity

PB1294 - Assessment of Factor IX Padua activity with a one-stage clotting method and with FXIa- and tissue factor/FVIIa-based chromogenic methods

PB1295 - Recombinant Factor IX fused with albumin (rFIX-HSA) is underassigned by one-stage methods with silica as contact activator

More information

  

2016-06-22 Publication in collaboration with NovoNordisk

Rosén P, Rosén S, Ezban M, Persson E.

Overestimation of N-glycoPEGylated factor IX activity in one-stage factor IX clotting assay owing to silica-mediated premature conversion to activated factor IX.

J Thromb Haemost 2016; 14: 1420-7.

  

2015-04-13 Publication in collaboration with AstraZeneca

Ann Lövgren et al. Blood Coagulation and Fibrinolysis, Characterization of thrombin derived from 

human recombinant prothrombin.

Open access: click here

  

Search